GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 25, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on March 25, 2025, that it purchased a certain number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of share repurchases and does not contain significant new risks.
Key Players & Entities
- GSK plc (company) — The company making the share repurchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker executing the share repurchase on behalf of GSK.
- March 2025 (date) — The reporting period for the transactions.
FAQ
What is the total number of GSK plc ordinary shares purchased?
The filing states that GSK plc purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What is the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the share repurchases.
On what specific dates in March 2025 did GSK plc purchase shares?
The filing mentions 'Date of pur' indicating a date was intended to follow, but the specific dates of purchase are not detailed in the provided text.
Who is GSK plc's corporate stockbroker for these transactions?
GSK plc is acting through its corporate stockbroker, Citigroup Global Markets Limited.
What is the par value of GSK plc's ordinary shares?
The ordinary shares are of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 25, 2025 regarding GSK plc (GLAXF).